A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)
Clinical trial NCT00506389 · COMPLETED
Trial details
- NCT number
- NCT00506389
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-06
- Primary completion
- 2008-02-13
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.